Interleukin
From Proteopedia
(Difference between revisions)
Line 29: | Line 29: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | + | *IL-1 α | |
- | [[2ila]] - hIL-1 α - human<BR /> | + | **[[2ila]] - hIL-1 α - human<BR /> |
- | [[2kki]] - hIL-1 α residues 121-271 <BR /> | + | **[[2kki]] - hIL-1 α residues 121-271 <BR /> |
- | [[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> | + | **[[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> |
- | + | *IL-1 β | |
- | [[2wry]] - cIL-1 β – chicken<BR /> | + | **[[2wry]] - cIL-1 β – chicken<BR /> |
- | [[3nj5]] – cIL-1 β (mutant) <BR /> | + | **[[3nj5]] – cIL-1 β (mutant) <BR /> |
- | [[2nvh]], [[9ilb]], [[1iob]], [[5i1b]], [[2i1b]], [[4i1b]], [[1i1b]] - hIL-1 β | + | **[[2nvh]], [[9ilb]], [[1iob]], [[5i1b]], [[2i1b]], [[4i1b]], [[1i1b]] - hIL-1 β |
- | [[1tp0]], [[1t4q]], [[1too]], [[1twe]], [[1twm]], [[1s0l]], [[1l2h]], [[1hib]], [[21bi]], [[31bi]], [[41bi]] - hIL-1 β (mutant) <BR /> | + | **[[1tp0]], [[1t4q]], [[1too]], [[1twe]], [[1twm]], [[1s0l]], [[1l2h]], [[1hib]], [[21bi]], [[31bi]], [[41bi]] - hIL-1 β (mutant) <BR /> |
- | [[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> | + | **[[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> |
- | [[3ltq]] - hIL-1 β residues 117-269 <BR /> | + | **[[3ltq]] - hIL-1 β residues 117-269 <BR /> |
- | [[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | + | **[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> |
- | [[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | + | **[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> |
- | [[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | + | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> |
- | [[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | + | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> |
- | [[4g6j]], [[4g6m]] - hIL-1 β + antibody<br /> | + | **[[4g6j]], [[4g6m]] - hIL-1 β + antibody<br /> |
- | [[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | + | **[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> |
- | [[1md6]] – mIL-1F5 – mouse<BR /> | + | **[[1md6]] – mIL-1F5 – mouse<BR /> |
- | [[2mib]], [[8i1b]] - mIL-1 β | + | **[[2mib]], [[8i1b]] - mIL-1 β |
- | + | *IL-2 (T-cell growth factor) | |
- | [[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | + | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> |
- | [[3qb1]] - hIL-2 (mutant)<br /> | + | **[[3qb1]] - hIL-2 (mutant)<br /> |
- | [[1irl]] – hIL-2 (mutant) - NMR<BR /> | + | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> |
- | [[2erj]], [[2b5i]] - hIL-2 + IL-2 receptor α and β + cytokine receptor common γ<BR /> | + | **[[2erj]], [[2b5i]] - hIL-2 + IL-2 receptor α and β + cytokine receptor common γ<BR /> |
- | [[1z92]] - hIL-2 + IL-2 receptor α<BR /> | + | **[[1z92]] - hIL-2 + IL-2 receptor α<BR /> |
- | [[3qaz]] - hIL-2 + IL-2 receptor β and γ<BR /> | + | **[[3qaz]] - hIL-2 + IL-2 receptor β and γ<BR /> |
- | [[1qvn]], [[1nbp]], [[1m4a]], [[1m4b]] – hIL-2 (mutant) + inhibitor<BR /> | + | **[[1qvn]], [[1nbp]], [[1m4a]], [[1m4b]] – hIL-2 (mutant) + inhibitor<BR /> |
- | [[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | + | **[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> |
- | + | *IL-3 | |
- | [[1jli]] – hIL-3 (mutant) – NMR<BR /> | + | **[[1jli]] – hIL-3 (mutant) – NMR<BR /> |
- | [[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | + | **[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR |
- | + | *IL-4 | |
- | [[2b8u]], [[1hik]], [[2int]], [[1rcb]] – hIL-4<BR /> | + | **[[2b8u]], [[1hik]], [[2int]], [[1rcb]] – hIL-4<BR /> |
- | [[2cyk]], [[1cyl]], [[1itm]], [[1bbn]], [[1bcn]], [[1iti]], [[1itl]] – hIL-4 - NMR<BR /> | + | **[[2cyk]], [[1cyl]], [[1itm]], [[1bbn]], [[1bcn]], [[1iti]], [[1itl]] – hIL-4 - NMR<BR /> |
- | [[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[1hzi]], [[1hij]] - hIL-4 (mutant) <BR /> | + | **[[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[1hzi]], [[1hij]] - hIL-4 (mutant) <BR /> |
- | [[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> | + | **[[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> |
- | [[3bpl]] - hIL-4 + IL-4 receptor α + cytokine receptor common γ<BR /> | + | **[[3bpl]] - hIL-4 + IL-4 receptor α + cytokine receptor common γ<BR /> |
- | [[3qb7]] - hIL-4 + cytokine receptor common γ<BR /> | + | **[[3qb7]] - hIL-4 + cytokine receptor common γ<BR /> |
- | [[3bpn]] - hIL-4 + IL-4 receptor α + IL-13 receptor α | + | **[[3bpn]] - hIL-4 + IL-4 receptor α + IL-13 receptor α |
- | + | *IL-5 | |
- | [[1hul]] – hIL-5<BR /> | + | **[[1hul]] – hIL-5<BR /> |
- | [[3b5k]] – mIL-5<br /> | + | **[[3b5k]] – mIL-5<br /> |
- | [[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> | + | **[[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> |
- | [[3va2]] - hIL-5 + IL-5 receptor α <BR /> | + | **[[3va2]] - hIL-5 + IL-5 receptor α <BR /> |
- | + | *IL-6 | |
- | [[1alu]] – hIL-6<BR /> | + | **[[1alu]] – hIL-6<BR /> |
- | [[2l3y]] - mIL-6 residues 27-211 - NMR<br /> | + | **[[2l3y]] - mIL-6 residues 27-211 - NMR<br /> |
- | [[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | + | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> |
- | [[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | + | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> |
- | [[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8<br /> | + | **[[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8<br /> |
- | [[4j4l]] – hIL-6 + internalin B<BR /> | + | **[[4j4l]] – hIL-6 + internalin B<BR /> |
- | [[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> | + | **[[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> |
- | + | *IL-7 | |
- | [[3di2]], [[3di3]] - hIL-7 residues 26-177 + IL-7 receptor α ectodomain | + | **[[3di2]], [[3di3]] - hIL-7 residues 26-177 + IL-7 receptor α ectodomain |
- | + | *IL-8 | |
- | [[3il8]] – hIL-8<BR /> | + | **[[3il8]] – hIL-8<BR /> |
- | [[1il8]], [[2il8]] – hIL-8]- NMR<BR /> | + | **[[1il8]], [[2il8]] – hIL-8]- NMR<BR /> |
- | [[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | + | **[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> |
- | [[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | + | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> |
- | [[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | + | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> |
- | [[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | + | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide |
- | + | *IL-10 | |
- | [[2h24]], [[1inr]], [[2ilk]], [[1ilk]] – hIL-10<BR /> | + | **[[2h24]], [[1inr]], [[2ilk]], [[1ilk]] – hIL-10<BR /> |
- | [[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> | + | **[[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> |
- | [[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α | + | **[[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α |
- | + | *IL-10 viral | |
- | [[1vlk]] - hvIL-10 residues 26-170 - human herpesvirus 4<BR /> | + | **[[1vlk]] - hvIL-10 residues 26-170 - human herpesvirus 4<BR /> |
- | [[1y6m]] - hvIL-10 residues 26-170 + IL-10 receptor α <BR /> | + | **[[1y6m]] - hvIL-10 residues 26-170 + IL-10 receptor α <BR /> |
- | [[1y6n]] - hvIL-10 residues 26-170 (mutant) + IL-10 receptor α <BR /> | + | **[[1y6n]] - hvIL-10 residues 26-170 (mutant) + IL-10 receptor α <BR /> |
- | [[1lqs]] - hvIL-10 residues 20-176 + IL-10 receptor α - human herpesvirus 5<BR /> | + | **[[1lqs]] - hvIL-10 residues 20-176 + IL-10 receptor α - human herpesvirus 5<BR /> |
- | [[1lk3]] - hvIL-10 residues 26-175 + antibody | + | **[[1lk3]] - hvIL-10 residues 26-175 + antibody |
- | + | *IL-12 | |
- | [[1f45]] - hIL-12 α and β (mutant) <BR /> | + | **[[1f45]] - hIL-12 α and β (mutant) <BR /> |
- | [[1f42]] - hIL-12 β P40 domain<BR /> | + | **[[1f42]] - hIL-12 β P40 domain<BR /> |
- | [[3hmx]] - hIL-12 α and β+ antibody<br /> | + | **[[3hmx]] - hIL-12 α and β+ antibody<br /> |
- | [[3qwr]] - hIL-12 β + hIL- 23 α + adnectin | + | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin |
- | + | *IL-13 | |
- | [[1ijz]], [[1ik0]] – hIL-13 – NMR<BR /> | + | **[[1ijz]], [[1ik0]] – hIL-13 – NMR<BR /> |
- | [[1ga3]] - hIL-13 residues 21-132 - NMR<BR /> | + | **[[1ga3]] - hIL-13 residues 21-132 - NMR<BR /> |
- | [[3l5w]], [[3l5x]], [[3l5y]], [[3g6d]], [[4i77]], [[4ps4]] - hIL-13 residues 35-146 + antibody<BR /> | + | **[[3l5w]], [[3l5x]], [[3l5y]], [[3g6d]], [[4i77]], [[4ps4]] - hIL-13 residues 35-146 + antibody<BR /> |
- | [[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | + | **[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> |
- | [[3bpo]] - hIL-13 + IL-4 receptor α + IL-13 receptor α | + | **[[3bpo]] - hIL-13 + IL-4 receptor α + IL-13 receptor α |
- | + | *IL-15 | |
- | [[2xqb]] – hIL-15 + antibody<BR /> | + | **[[2xqb]] – hIL-15 + antibody<BR /> |
- | [[2psm]], [[2z3q]], [[2z3r]] - hIL-15 + IL-15 receptor α<br /> | + | **[[2psm]], [[2z3q]], [[2z3r]] - hIL-15 + IL-15 receptor α<br /> |
- | [[4gs7]] - hIL-15 + IL-15 receptor α + IL-2 receptor β,γ <br /> | + | **[[4gs7]] - hIL-15 + IL-15 receptor α + IL-2 receptor β,γ <br /> |
- | + | *IL-16 | |
- | [[1i16]] – hIL-16 - NMR<BR /> | + | **[[1i16]] – hIL-16 - NMR<BR /> |
- | [[1x6d]] – hIL-16 PDZ domain – NMR<BR /> | + | **[[1x6d]] – hIL-16 PDZ domain – NMR<BR /> |
- | + | *IL-17 | |
- | [[4hr9]] - hIL-17A (mutant)<br /> | + | **[[4hr9]] - hIL-17A (mutant)<br /> |
- | [[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | + | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> |
- | [[2vxs]] - hIL-17A residues 20-255 + antibody<BR /> | + | **[[2vxs]] - hIL-17A residues 20-255 + antibody<BR /> |
- | [[1jpy]] – hIL-17F<BR /> | + | **[[1jpy]] – hIL-17F<BR /> |
- | [[3jvf]] - hIL-17F + IL-17 receptor α | + | **[[3jvf]] - hIL-17F + IL-17 receptor α |
- | + | *IL-18 (Interferon-γ inducing factor) | |
- | [[1j0s]] – hIL-18 - NMR<BR /> | + | **[[1j0s]] – hIL-18 - NMR<BR /> |
- | [[4hjj]] - hIL-18 + antibody<br /> | + | **[[4hjj]] - hIL-18 + antibody<br /> |
- | [[2vxt]] - hIL-18 (mutant) + antibody<BR /> | + | **[[2vxt]] - hIL-18 (mutant) + antibody<BR /> |
- | [[3f62]] - hIL-18 residues 37-193 (mutant) + IL-18 binding protein<br /> | + | **[[3f62]] - hIL-18 residues 37-193 (mutant) + IL-18 binding protein<br /> |
- | [[4eee]], [[4ekx]] - hIL-18 (mutant) + 14L protein | + | **[[4eee]], [[4ekx]] - hIL-18 (mutant) + 14L protein |
- | + | *IL-19 | |
- | [[1n1f]] – hIL-19 | + | **[[1n1f]] – hIL-19 |
- | + | *IL-20 | |
- | [[4doh]] - hIL-20 + IL-20 receptor α,β <BR /> | + | **[[4doh]] - hIL-20 + IL-20 receptor α,β <BR /> |
- | + | *IL-21 | |
- | [[2oqp]]– hIL-21 – NMR<BR /> | + | **[[2oqp]]– hIL-21 – NMR<BR /> |
- | [[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> | + | **[[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> |
- | + | *IL-22 | |
- | [[1ykb]], [[1m4r]] – hIL-22<BR /> | + | **[[1ykb]], [[1m4r]] – hIL-22<BR /> |
- | [[3g9v]] - hIL-22 residues 29-179 + IL-22 receptor α2<BR /> | + | **[[3g9v]] - hIL-22 residues 29-179 + IL-22 receptor α2<BR /> |
- | [[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | + | **[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> |
- | [[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody | + | **[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody |
- | + | *IL-23 | |
- | [[3d87]] - hIL-23 α<BR /> | + | **[[3d87]] - hIL-23 α<BR /> |
- | [[3d85]] - hIL-23 α + antibody<BR /> | + | **[[3d85]] - hIL-23 α + antibody<BR /> |
- | [[4grw]] - hIL-23 α + + hIL-12 β + nanobody<BR /> | + | **[[4grw]] - hIL-23 α + + hIL-12 β + nanobody<BR /> |
- | [[3duh]] - hIL-23 α + hIL-12 β | + | **[[3duh]] - hIL-23 α + hIL-12 β |
- | + | *IL-28 | |
- | [[3hhc]] – hIL-28B | + | **[[3hhc]] – hIL-28B |
- | + | *IL-29 | |
- | [[3og4]], [[3og6]] – hIL-29 + IL-28 receptor α | + | **[[3og4]], [[3og6]] – hIL-29 + IL-28 receptor α |
+ | *IL-33 | ||
- | + | **[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | |
- | + | *IL-34 | |
- | + | **[[4dkc]] - hIL-34<br /> | |
- | + | **[[4exn]] - mIL-34<br /> | |
- | [[4dkc]] - hIL-34<br /> | + | **[[4dkd]] - hIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> |
- | [[4exn]] - mIL-34<br /> | + | **[[4exp]] - mIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> |
- | [[4dkd]] - hIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | + | **[[4dke]], [[4dkf]] - hIL-34 active core + antibody |
- | [[4exp]] - mIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | + | }} |
- | [[4dke]], [[4dkf]] - hIL-34 active core + antibody | + | [[Category: Topic Page]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 12:11, 27 November 2014
Template:STRUCTURE 2nvh
Interleukin (IL) is a cytokine which functions in the immune system. IL deficiency results in autoimmune disease. IL families are denoted by numbers.
- IL-1 is a group of 11 cytokines which regulate immune and inflammatory response. See Interleukin-1 beta.
- IL-2 is a cytokine made by leukocytes. It is used in cancer therapy to boost the immune system.
- IL-3 improves the body's natural response to disease by stimulating the differentiation of multipotent hematopoietic stem cells into myeloid or lymphoid progenitor cells.
- IL-4 induces the differentiation of naive helper T cells (Th0) to Th2 cells.
- IL-5 stimulates B cell growth and increases immunoglobulin secretion.
- IL-6 is both a pro-inflammatory cytokine and anti-inflammatory myokine.
- IL-7 is a cytokine important for B and T cells development.
- IL-8 induces chemotaxis and phagocytosis.
- IL-10 see Interleukin-10.
- IL-12 induces the differentiation of naive helper T cells (Th0) to Th1 cells.
- IL-13 induces the differentiation of naive helper T cells (Th0) to Th2 cells.
- IL-15 see Interleukin-15.
- IL-16 acts as chemoattractant, modulator of T cell activity and inhibitor of HIV replication.
- IL-17 recruits monocytes and neutrophils to the site of inflammation.
- IL-18 induces cell-mediated immunity following infection by microbial lipopolysaccharides.
- IL-19 induces activation of the signal transducer and activator of STAT3.
- IL-21 has potent effect on natural killer cells.
- IL-22 stimulates inflammatory responses like S100 and defensin.
- IL-23 induces activation of the signal transducer and activator of STAT4.
- IL-28 has a role in the immune defense against viruses.
- IL-29 similar to IL-28.
- IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines.
- IL-34 increases growth or survival of monocytes.
3D structures of interleukin
Updated on 27-November-2014